✦ LIBER ✦

Absolute monocyte count in follicular lymphoma patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone

✍ Scribed by Watanabe, Reina; Tomita, Naoto; Kishimoto, Kumiko; Koyama, Satoshi; Ogusa, Eriko; Ishii, Yoshimi; Miyashita, Kazuho; Matsuura, Shiro; Fujisawa, Shin; Hattori, Yukako; Takasaki, Hirotaka; Fujita, Atsuko; Ohshima, Rika; Kuwabara, Hideyuki; Hashimoto, Chizuko; Fujimaki, Katsumichi; Sakai, Rika; Ishigatsubo, Yoshiaki

Book ID: 122794830
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 612 KB
Volume: 37
Category: Article
ISSN: 0145-2126
DOI: 10.1016/j.leukres.2013.07.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Activity of Rituximab plus Cyclophospham

Activity of Rituximab plus Cyclophosphamide, Doxorubicin/Mitoxantrone, Vincristine and Prednisone in Patients with Relapsed MALT Lymphoma

✍ Raderer, Markus; Wöhrer, Stefan; Streubel, Berthold; Drach, Johannes; J&aum 📂 Article 📅 2006 🏛 S. Karger AG 🌐 English ⚖ 155 KB

Prognostic significance of MYC, BCL2, an

Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab

✍ Nalan Akyurek; Aysegul Uner; Mustafa Benekli; Ibrahim Barista 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 399 KB

Epratuzumab with rituximab, cyclophospha

Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma

✍ Micallef, I. N. M.; Maurer, M. J.; Wiseman, G. A.; Nikcevich, D. A.; Kurtin, P. 📂 Article 📅 2011 🏛 American Society of Hematology 🌐 English ⚖ 193 KB

Liposome-encapsulated doxorubicin in com

Liposome-encapsulated doxorubicin in combination with cyclophosphamide, vincristine, prednisone and rituximab in patients with lymphoma and concurrent cardiac diseases or pre-treated with anthracyclines

✍ Luigi Rigacci; Silvia Mappa; Luca Nassi; Renato Alterini; Valentina Carrai; Fran 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB

## Abstract ## Background To assess the efficacy and safety of the combination of non‐pegylated liposome‐encapsulated doxorubicin (Myocet®) with cyclophosphamide, vincristine, prednisone and rituximab (R‐COMP) in patients with aggressive non‐Hodgkin's B‐cell lymphomas. ## Methods Twenty‐one pati

Intrathecal methotrexate prophylaxis and

Intrathecal methotrexate prophylaxis and central nervous system relapse in patients with diffuse large B-cell lymphoma following rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone

✍ Tomita, Naoto; Takasaki, Hirotaka; Ishiyama, Yasufumi; Kishimoto, Kumiko; Ishiba 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 351 KB

Proliferation predicts failure-free surv

Proliferation predicts failure-free survival in mantle cell lymphoma patients treated with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with rituximab plus high-dose methotrexate and cytarabine

✍ Mar Garcia; Jorge E. Romaguera; Kedar V. Inamdar; George Z. Rassidakis; L. Jeffr 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 393 KB 👁 1 views